Financial Ratios

LOTUS EYE HOSPITAL AND INSTITUTE LTD.

NSE : LOTUSEYEBSE : 532998ISIN CODE : INE947I01017Industry : Hospital & Healthcare ServicesHouse : Private
BSE74.00-0.91 (-1.21 %)
PREV CLOSE ( ) 74.91
OPEN PRICE ( ) 76.98
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 953
TODAY'S LOW / HIGH ( )74.00 76.98
52 WK LOW / HIGH ( )44.1 110.9
NSE75.180.41 (+0.55 %)
PREV CLOSE( ) 74.77
OPEN PRICE ( ) 78.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 14630
TODAY'S LOW / HIGH( ) 73.50 78.50
52 WK LOW / HIGH ( )48.5 111
Select year
ParticularsMar2024Mar2023Mar2022Mar2021Mar2020
Operational & Financial Ratios
   Earnings Per Share (Rs)1.401.961.440.750.51
   CEPS(Rs)3.193.392.641.871.71
   DPS(Rs)0.500.500.500.500.00
   Book NAV/Share(Rs)28.5727.6926.2625.3424.65
   Tax Rate(%)27.3927.8627.0921.2926.86
Margin Ratios
   Core EBITDA Margin(%)13.7616.3515.2511.239.82
   EBIT Margin(%)8.7412.4511.076.584.17
   Pre Tax Margin(%)8.3312.0110.526.153.59
   PAT Margin (%)6.058.677.674.842.63
   Cash Profit Margin (%)13.7815.0014.1012.048.78
Performance Ratios
   ROA(%)4.516.584.992.711.89
   ROE(%)4.987.275.563.022.10
   ROCE(%)7.1910.438.004.073.32
   Asset Turnover(x)0.750.760.650.560.72
   Sales/Fixed Asset(x)0.510.530.460.400.50
   Working Capital/Sales(x)6.194.945.474.168.71
Efficiency Ratios
   Fixed Capital/Sales(x)1.951.892.172.522.00
   Receivable days9.206.976.407.906.41
   Inventory Days22.7219.7719.1621.9519.21
   Payable days78.7081.7696.13106.9887.95
Valuation Parameters
   PER(x)40.3129.6237.1855.5745.52
   PCE(x)17.6917.1120.2322.3513.61
   Price/Book(x)1.982.102.031.650.95
   Yield(%)0.880.860.941.190.00
   EV/Net Sales(x)2.302.392.632.391.03
   EV/Core EBITDA(x)13.9512.7114.9917.708.55
   EV/EBIT(x)26.2619.1923.7336.3924.67
   EV/CE(x)1.861.951.671.330.73
   M Cap / Sales2.442.572.852.691.19
Growth Ratio
   Net Sales Growth(%)2.4820.9020.21-20.185.54
   Core EBITDA Growth(%)-10.2129.6255.74-10.3125.14
   EBIT Growth(%)-28.0335.94102.3125.78101.06
   PAT Growth(%)-28.5236.6390.3347.2950.37
   EPS Growth(%)-28.5236.6290.3347.2950.37
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.000.010.01
   Current Ratio(x)2.252.832.242.341.79
   Quick Ratio(x)1.742.301.832.031.43
   Interest Cover(x)20.9828.6920.0915.527.13
   Total Debt/Mcap(x)0.000.000.000.000.01

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.